Thomas Coyle

2.4k total citations
34 papers, 1.1k citations indexed

About

Thomas Coyle is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Thomas Coyle has authored 34 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hematology, 12 papers in Genetics and 7 papers in Molecular Biology. Recurrent topics in Thomas Coyle's work include Glioma Diagnosis and Treatment (6 papers), Hemophilia Treatment and Research (6 papers) and Platelet Disorders and Treatments (5 papers). Thomas Coyle is often cited by papers focused on Glioma Diagnosis and Treatment (6 papers), Hemophilia Treatment and Research (6 papers) and Platelet Disorders and Treatments (5 papers). Thomas Coyle collaborates with scholars based in United States, Germany and Netherlands. Thomas Coyle's co-authors include Jeffrey A. Winfield, Vesna Najfeld, Anita Shah, Lisa A. Michaels, Mark T. Reding, Jerry S. Powell, Peter Bushunow, Jennifer Lin, Gordon Starkebaum and Bernard J. Poiesz and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Thomas Coyle

32 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Coyle United States 18 343 308 287 243 132 34 1.1k
John B. Miller United States 15 200 0.6× 195 0.6× 96 0.3× 234 1.0× 215 1.6× 40 961
F. M. Sirotnak United States 19 111 0.3× 404 1.3× 83 0.3× 124 0.5× 301 2.3× 42 1.0k
Marina Parry United Kingdom 16 245 0.7× 382 1.2× 110 0.4× 101 0.4× 171 1.3× 34 1.0k
Seiichi Okamura Japan 20 323 0.9× 302 1.0× 162 0.6× 632 2.6× 563 4.3× 85 1.6k
İlyas Şahin United States 19 148 0.4× 516 1.7× 207 0.7× 273 1.1× 339 2.6× 70 1.3k
N Génetet France 18 140 0.4× 261 0.8× 71 0.2× 509 2.1× 205 1.6× 54 1.0k
Isao Nakano Japan 26 67 0.2× 268 0.9× 79 0.3× 131 0.5× 115 0.9× 106 1.9k
Ken Sato Japan 14 200 0.6× 496 1.6× 95 0.3× 433 1.8× 197 1.5× 43 1.0k
Philippa L. Roddam United Kingdom 14 223 0.7× 613 2.0× 56 0.2× 212 0.9× 187 1.4× 19 1.1k
Xueyan Xi China 16 110 0.3× 418 1.4× 27 0.1× 492 2.0× 225 1.7× 49 1.2k

Countries citing papers authored by Thomas Coyle

Since Specialization
Citations

This map shows the geographic impact of Thomas Coyle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Coyle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Coyle more than expected).

Fields of papers citing papers by Thomas Coyle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Coyle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Coyle. The network helps show where Thomas Coyle may publish in the future.

Co-authorship network of co-authors of Thomas Coyle

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Coyle. A scholar is included among the top collaborators of Thomas Coyle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Coyle. Thomas Coyle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Stoppacher, Robert, et al.. (2017). Complete response to temozolomide in chronic lymphocytic leukemia. Clinical Case Reports. 5(7). 1130–1131. 2 indexed citations
3.
Kothari, Shalin, et al.. (2016). Crizotinib in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma in the setting of renal insufficiency: a case report. Journal of Medical Case Reports. 10(1). 176–176. 2 indexed citations
4.
Ragni, Margaret V., Lynn Malec, Donald Brambilla, et al.. (2015). Von Willebrand Factor for Menorrhagia: A Survey and Literature Review. Blood. 126(23). 4694–4694.
5.
Schiff, David, Santosh Kesari, John de Groot, et al.. (2014). Phase 2 study of CT-322, a targeted biologic inhibitor of VEGFR-2 based on a domain of human fibronectin, in recurrent glioblastoma. Investigational New Drugs. 33(1). 247–253. 42 indexed citations
6.
Peters, Katherine B., Thomas Coyle, James J. Vredenburgh, et al.. (2010). Ulceration of Striae distensae in high-grade glioma patients on concurrent systemic corticosteroid and bevacizumab therapy. Journal of Neuro-Oncology. 101(1). 155–159. 12 indexed citations
7.
Coyle, Thomas, et al.. (2008). Rituximab as an adjunct to plasma exchange in TTP: A report of 12 cases and review of literature. Journal of Clinical Apheresis. 23(5). 151–156. 60 indexed citations
8.
Coyle, Thomas, et al.. (2005). Acute leukemia associated with valproic acid treatment: A novel mechanism for leukemogenesis?. American Journal of Hematology. 78(4). 256–260. 25 indexed citations
9.
Korones, David N., Thomas Coyle, László Mechtler, et al.. (2003). Phase I study of temozolomide and escalating doses of oral etoposide for adults with recurrent malignant glioma. Cancer. 97(8). 1963–1968. 36 indexed citations
10.
Coyle, Thomas, et al.. (2000). Successful inguinal herniorraphy in a patient with congenital factor VII deficiency using recombinant factor VNA concentrate (novoseven). Blood. 96. 1 indexed citations
11.
Gajra, Ajeet, et al.. (2000). Hematin induced coagulopathy in acute intermittent porphyria: A case report. Blood. 96. 2 indexed citations
12.
Bushunow, Peter, Marcus M. Reidenberg, John J. Wasenko, et al.. (1999). Gossypol Treatment of Recurrent Adult Malignant Gliomas. Journal of Neuro-Oncology. 43(1). 79–86. 114 indexed citations
13.
Maness, Lori J., Donald C. Blair, Nancy Newman, & Thomas Coyle. (1998). Elevation of Platelet Counts Associated with Indinavir Treatment in Human Immunodeficiency Virus‐Infected Patients. Clinical Infectious Diseases. 26(1). 207–208. 8 indexed citations
14.
Coyle, Thomas. (1997). HEMATOLOGIC COMPLICATIONS OF HUMAN IMMUNODEFICIENCY VIRUS INFECTION AND THE ACQUIRED IMMUNODEFICIENCY SYNDROME. Medical Clinics of North America. 81(2). 449–470. 114 indexed citations
15.
Lehmann, David F., et al.. (1997). Anticonvulsant usage is associated with an increased risk of procarbazine hypersensitivity reactions in patients with brain tumors. Clinical Pharmacology & Therapeutics. 62(2). 225–229. 28 indexed citations
16.
Coyle, Thomas, et al.. (1994). Moderate hemophilia B leyden: Identification by polymerase chain reaction, sequencing, and oligomer restriction. American Journal of Hematology. 46(3). 234–240. 2 indexed citations
17.
Coyle, Thomas, et al.. (1994). In vitro andin vivo cytotoxicity of gossypol against central nervous system tumor cell lines. Journal of Neuro-Oncology. 19(1). 25–35. 91 indexed citations
18.
Loughran, Thomas P., Michael P. Sherman, Francis W. Ruscetti, et al.. (1994). Prototypical HTLV-I/II infection is rare in LGL leukemia. Leukemia Research. 18(6). 423–429. 40 indexed citations
19.
Coyle, Thomas, Peter Bushunow, Jeffrey A. Winfield, Jonathan Wright, & Stephen L. Graziano. (1992). Hypersensitivity reactions to procarbazine with mechlorethamine, vincristine, and procarbazine chemotherapy in the treatment of glioma. Cancer. 69(10). 2532–2540. 20 indexed citations
20.
Coyle, Thomas & Vesna Najfeld. (1988). Translocation (3;21) in Philadelphia chromosome—positive chronic myelogenous leukemia prior to the onset of blast crisis. American Journal of Hematology. 27(1). 56–59. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026